The Efficacy of 17Beta-Estradiol in Postpartum-Related Depressive Illness.

Trial Profile

The Efficacy of 17Beta-Estradiol in Postpartum-Related Depressive Illness.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 31 Jan 2017

At a glance

  • Drugs Estradiol (Primary)
  • Indications Postnatal depression
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Nov 2016 Status changed from recruiting to discontinued.
    • 05 May 2016 Planned End Date changed from 1 Jan 2017 to 1 Jan 2018.
    • 01 Feb 2016 Planned End Date changed from 1 Jan 2016 to 1 Jan 2017, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top